Literature DB >> 19646764

Determinants of work outcome in schizophrenia and schizoaffective disorder: role of cognitive function.

Yasuhiro Kaneda1, Karuna Jayathilak, Herbert Y Meltzer.   

Abstract

Cognitive impairment has been reported to be more important than clinical symptomatology as a determinant of work and social function in schizophrenia. In a retrospective analysis of a group of 152 patients with chronic schizophrenia or schizoaffective disorder, performance on a battery of neuropsychological tests was contrasted in employed (32, 21.1%) versus unemployed subgroups. As predicted, neurocognitive performance was more important than clinical symptoms in predicting employment status. Among neurocognitive functions, verbal working memory (as reflected by the Consonant Trigram Test) was the strongest predictor of employment status.

Entities:  

Mesh:

Year:  2009        PMID: 19646764     DOI: 10.1016/j.psychres.2008.08.003

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  12 in total

1.  Cognitive remediation therapy needs funding.

Authors:  Til Wykes
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

2.  Cognitive and serum BDNF correlates of BDNF Val66Met gene polymorphism in patients with schizophrenia and normal controls.

Authors:  Xiang Yang Zhang; Da Chun Chen; Mei Hong Xiu; Colin N Haile; Xingguang Luo; Ke Xu; Hui Ping Zhang; Lingjun Zuo; Zhijun Zhang; Xiangrong Zhang; Therese A Kosten; Thomas R Kosten
Journal:  Hum Genet       Date:  2012-02-24       Impact factor: 4.132

3.  Cognitive and Social Functioning Correlates of Employment Among People with Severe Mental Illness.

Authors:  Javier Saavedra; Marcelino López; Sergio González; Samuel Arias; Paul Crawford
Journal:  Community Ment Health J       Date:  2015-04-21

4.  Clinical and cognitive correlates of employment among patients with schizophrenia: a cross-sectional study in Malaysia.

Authors:  Marhani Midin; Rosdinom Razali; Ruzanna Zamzam; Aaron Fernandez; Lim C Hum; Shamsul A Shah; Rozhan Sm Radzi; Hazli Zakaria; Aishvarya Sinniah
Journal:  Int J Ment Health Syst       Date:  2011-05-30

5.  The effects of the combination of cognitive training and supported employment on improving clinical and working outcomes for people with schizophrenia in Japan.

Authors:  Sayaka Sato; Kazuhiko Iwata; Shun-Ichi Furukawa; Yasuhiro Matsuda; Norifumi Hatsuse; Emi Ikebuchi
Journal:  Clin Pract Epidemiol Ment Health       Date:  2014-02-07

6.  The Cannabis Pathway to Non-Affective Psychosis may Reflect Less Neurobiological Vulnerability.

Authors:  Else-Marie Løberg; Siri Helle; Merethe Nygård; Jan Øystein Berle; Rune A Kroken; Erik Johnsen
Journal:  Front Psychiatry       Date:  2014-11-18       Impact factor: 4.157

7.  Combined use of electroconvulsive therapy and antipsychotics (both clozapine and non-clozapine) in treatment resistant schizophrenia: A comparative meta-analysis.

Authors:  Saeed Ahmed; Ali Mahmood Khan; Hema Madhuri Mekala; Hema Venigalla; Rizwan Ahmed; Amira Etman; Michael Esang; Mustafa Qureshi
Journal:  Heliyon       Date:  2017-11-03

Review 8.  A critical review of pro-cognitive drug targets in psychosis: convergence on myelination and inflammation.

Authors:  Rune A Kroken; Else-Marie Løberg; Tore Drønen; Renate Grüner; Kenneth Hugdahl; Kristiina Kompus; Silje Skrede; Erik Johnsen
Journal:  Front Psychiatry       Date:  2014-02-04       Impact factor: 4.157

9.  The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis.

Authors:  Erik Johnsen; Farivar Fathian; Rune A Kroken; Vidar M Steen; Hugo A Jørgensen; Rolf Gjestad; Else-Marie Løberg
Journal:  BMC Psychiatry       Date:  2016-03-14       Impact factor: 3.630

10.  Vocational Profile and Correlates of Employment in People With Schizophrenia: The Role of Avolition.

Authors:  Mei San Ang; Gurpreet Rekhi; Jimmy Lee
Journal:  Front Psychiatry       Date:  2020-08-27       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.